Nestin, PDGFRβ, CXCL12 and VEGF in glioma patients: Different profiles of (pro-angiogenic) molecule expression are related with tumor grade and may provide prognostic information

Cancer Biology and Therapy

Volumn 6, Issue 7, 2007, Pages 1018-1024

  Maderna, Emanuela ^a   Salmaggi, Andrea ^a   Calatozzolo, Chiara ^a   Limido, Lucia ^a   Pollo, Bianca ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Angiogenesis; CXCL12; Glioma; Nestin; VEGF

Indexed keywords

NESTIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; CXCL12 PROTEIN, HUMAN; INTERMEDIATE FILAMENT PROTEIN; NERVE PROTEIN; VASCULOTROPIN A;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CELL PROLIFERATION; CHEMOTAXIS; ENDOTHELIUM CELL; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SURVIVAL TIME; UPREGULATION; BRAIN TUMOR; CANCER STAGING; CHEMISTRY; MIDDLE AGED; MORTALITY; PATHOLOGY; VASCULARIZATION;

ADULT; AGED; BRAIN NEOPLASMS; CHEMOKINE CXCL12; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; MALE; MIDDLE AGED; NEOPLASM STAGING; NERVE TISSUE PROTEINS; PROGNOSIS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 42449103074     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.7.4362     Document Type: Article

References (45)

1. Hanahan D, Folkman J. Pattern and emerging mechanism of the angiogenis switch during tumorigenesis. Cell 1996; 86:353-64.
2. Giatromanolaki A, Sivridis E, Koukourakis M. Tumor angiogenesis: Vascular growth and survival. APMIS 2004; 112:431-40.
3. Birner P, Piribauer M, Fisher I, Gatterbauer B, Marosi C, Ambros PF, Ambros IM, Bredel M, Oberhuber G, Rossler K, Budka H, Harris AL, Hainfellner JA. Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: Evidence for distinct angiogenic subtypes. Brain Pathol 2003; 13:133-43.
4. Dahlstrand J, Collins VP, Lendahl U. Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res 1992; 52:5334-41.
5. Messam CA, Hou J, Major EO. Coexpression of nestin in neural and glial cells in the developing human CNS defined by a human-specific anti-nestin antibody. Exp Neurol 2000;161:585-96.
6. Tohyama T, Lee VM, Rorke LB, Marvin M, McKay RDG, Trojanowski JQ. Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest 1992; 66:303-13.
7. Johansson CB, Hanna S, Clarke DL, Risling M, Lendhal U, Frisen J. Identification of a neural stem cells in the adult mammalian central nervous system. Cell 1999; 96:25-34.
8. Lendhal V, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell 1990; 60:585-95.
9. Alliot F, Rutin J, Leenen PJM, Pessac B. Pericytes and periendothelial cells of the brain parenchyma vessels coexpress aminopeptidase N, aminopeptidase A and nestin. J Neurosci Res 1999; 58:367-78.
10. Pekny M, Johansson CB, Eliasson C, Stakeberg J, Wallen A, Perlmann T, Lendahl U, Betsholtz C, Berthold CH, Frisen J. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J Cell Biol 1999; 145:503-14.
11. Shiffer D, Manazza A, Tamagno I. Nestin expression in neuroepithelial tumors. Neuroscience Letters 2006; In press.
12. Sugawara K, Kurihara H, Negishi M, Saito N, Nakazato Y, Sasaki T, Takeuchi T. Nestin as a marker for proliferative endothelium in gliomas. Lab Invest 2002; 82:345-51.
13. Mokry J, Cizkova D, Filip S, Ehrmann J, Osterreicher J, Kolar Z, English D. Nestin expression by newly formed human blood vessels. Stem Cells Dev 2004; 13:658-64.
14. Connolly DT, Hervelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84:1470-8.
15. Machein MR, Plate KM. VEGF in brain tumors. J. Neurooncol 2000; 50:109-20.
16. Zhang L, Yang N, Park JW, Katsaras D, Fracchiali S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilized host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res 2003; 63:3403-12.
17. Berkman RA, Merrill MJ, Reinhold WC, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Oldfield EH. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 1993; 91:153-9.
18. Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OMZ, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells. Am. Journal of Pathology 1999; 154:1125-35.
19. Volin MV, Joseph L, Shockley MS, Davies PF. Chemokine receptor CXCR4 expression in endothelium. Biochem Biophys Res Commun 1998; 242:46-53.
20. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant stromal cell-derived factor 1. J Exp Med 1996; 184:799-02.
21. Zhou Y, Larsen PH, Hao C, Yong VW. CXCR4 is a major chemokine receptor on glioma cells and mediated their survival. J Biol Chem 2002; 277:49481-7.
22. Guo P, Hu B, Gu W, Xu L, Wang D, Huang HJ, Cavenee WK, Cheng SY. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol 2003; 162:1083-93.
23. Rempel SA, Dudas S, Ge S, Gutierrez JA. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 2000; 6:102-11.
24. Plate KH, Breier G, Farrell CL, Risau W. Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab Invest 1992; 67:529-34.
25. Ehrmann J, Kalar Z, Makry J. Nestin as a diagnostic and prognastic marker immunohistochemical analysis of its expression in different tumors. J Clin Pathol 2005; 58:222-3.
26. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993; 3:255-68, (Review).
27. Zagzag D, Krishnamachary B, Yee H, Okuyama H, Chiriboga L, Ali MA, Melamed J, Semenza GL. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: Von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res 2005; 65:6178-88.
28. Wang D, Anderson JC, Gladson CL. The role of the extracellular matrix in angiogenesis in malignant glioma tumors. Brain Pathology 2005; 15:318-26.
29. Vaquero J, Zurita M, Coca S, Oya S, Morales C. Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas. Surg Neurol 2000;54:229-34.
30. Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre PL, Franceschi S, Ohgaki H. Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol 2006; 65:846-54.
31. Folkman J. Angiogenesis in cancer, vascular rheumatoid and other disease. Nature Med 1995; 1:27-31.
32. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjeimeland AB, Shi Q, McLendon RE, Bigner DD, Rich JN. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006; 66:7843-8.
33. Barbero S, Bonaria R, Bajetto A, Porcile C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T, Schettini G. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 2003; 63:1969-74.
34. Salmaggi A, Gelati M, Pollo B, Marras C, Silvani A, Balestrini MR, Eoli M, Fariselli L, Broggi G, Boiardi A. CXCL12 expression is predictive of a shorter time to progression in low-grade glioma: A single-Institution study in 50 patients. J Neurooncol 2005;74:287-93.
35. Salmaggi A, Gelati M, Pollo B, Frigerio S, Eoli M, Silvani A, Broggi G, Ciusani E, Croci D, Boiardi A, De Rossi M. CXCL12 in malignant glial tumors: A possible role in angiogenesis and cross-talk between endothelial and tumoral cells. J Neurooncol 2004; 67:305-17.
36. Daido S, Takao S, Tamiya T, Ono Y, Terada K, Ito S, Ouchida M, Date I, Ohmoto T, Shimizu K. Loss of heterozigosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss region. Oncol Rep 2004;12:789-95.
37. Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, Fukui M. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 1995; 55:1189-93.
38. Chaudhry IH, O'Donovan DG, Brenchley PE, Reid H, Roberts IS. Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas. Histopathology 2001; 39:409-15.
39. Abdulrauf SI, Edvardsen K, Ho KL, Yang XY, Rock JP, Rosenblum ML. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 1998; 88:513-20.
40. Korkolopoulou P, Patsouris E, Konstantinidou E, Pavlopoulos M, Kavantzas N, Boviatsis E, Thymara I, Perdiki M, Thomas-Tsagli E, Angelidakis D, Rologis D, Sakkas D. Hypoxia-inducible factor 1a/vascular endithelial growth factor axis astrocytoma. Associations with microvessel morphometry, proliferation and prognosis. Neuropathology and Applied Neurobiology 2004; 30:267-78.
41. Korshunov A, Golanov A. The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma: An analysis of 91 cases. Journal of Neuro-Oncology 2000; 48:13-9.
42. Salmaggi A, Eoli M, Frigerio S, Silvani A, Gelati M, Corsini E, Broggi G, Boiardi A. Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma. J Neurooncol 2003; 62:297-303.
43. Ribom D, Andrae J, Frielingsdorf M, Hartman M, Nistér M, Smits A. Prognostic value of platelet derived growth factor a receptor expression in grade 2 astrocytoma and oligoastrocytomas. J Neurol Neurosurg Psychiatry 2002; 72:782-7.
44. Varela M, Ranuncolo SM, Morand A, Lastiri J, De Kier Joffe EB, Puricelli LI, Pallotta MG. EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas. J Surg Oncol 2004; 86:34-40.
45. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, Nister M. Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 1992; 52:3213-9.